American College of Cardiology

NOVEMBER 12, 2024

The Centers for Medicare and Medicaid Services (CMS) released the 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center (ASC) final rule on Nov. The rule will implement a 2.9% increase to OPPS payment rates that reflects a market basket update of 3.4% reduced by a productivity adjustment of 0.5%.

Hospital 40

Hospital CMS Medicaid Medicare 40

American College of Cardiology

JULY 16, 2024

The Centers for Medicare and Medicaid Services (CMS) released the proposed 2025 Medicare Physician Fee Schedule (PFS) on July 10, addressing Medicare payment and quality provisions for physicians in the coming year. 1, 2025, dropping from $33.2875 to $32.3562.

Medicare 48

Medicare CMS Medicaid Article 48

American College of Cardiology

JULY 31, 2024

In response to the release of the proposed 2025 Medicare PFS on July 10, the ACC has developed the 2025 Medicare PFS Proposed Rule Calculator to allow clinicians and practice managers to estimate the potential impact of changes to practices.

Medicare 51

Medicare Medicaid Article 51

American College of Cardiology

SEPTEMBER 5, 2024

4, providing feedback and raising concerns on several issues of relevance to the cardiovascular community in the 2025 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. The ACC submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) on Sept.

Hospital 48

Hospital CMS Medicaid Medicare 48

DAIC

JULY 9, 2024

The American Heart Association, commemorating its 100th year, has announced its volunteer leadership for fiscal year 2024-2025, which includes Keith Churchwell, MD, FAHA, a cardiologist renowned as a health equity champion, and Marsha Jones, an executive leader in workplace diversity and inclusion.

Innovation 111

Innovation Health Disparities Cardiovascular Disease Medicaid 111

American College of Cardiology

JULY 18, 2024

The Centers for Medicare and Medicaid Services (CMS) released the proposed 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System rule on July 10. CMS proposes a 2.6% increase to OPPS payment rates that reflects a market basket update of 3.0%

Hospital 48

Hospital CMS Medicaid Medicare 48

American College of Cardiology

JULY 10, 2024

The Centers for Medicare and Medicaid Services (CMS) has released the proposed 2025 Medicare Physician Fee Schedule (PFS). Of note, the PFS conversion factor has been updated from $33.2875 to $32.3562, a 2.80% cut.

CMS 61

CMS Medicare Reimbursement Medicaid 61

American College of Cardiology

AUGUST 7, 2024

The Centers for Medicare and Medicaid Services (CMS) released the Fiscal Year (FY) 2025 Inpatient Prospective Payment System (IPPS) Final Rule on Aug. 1, including a 2.9% increase in operating payment rates for general acute care hospitals, representing a 3.4% increase in the hospital market basket with a 0.5%

CMS 48

CMS Medicaid Medicare Inpatient 48

Cassling

OCTOBER 21, 2024

While you weren’t looking, a lot has been happening in the field of ultrasound! New technologies, new workflows, new best practices. Over just a few short years, the potential uses of ultrasound have grown exponentially, and that means exciting things for you and your imaging team.

Ultrasound 83

Ultrasound Best Practices Technology Blog 83

Cardiometabolic Health Congress

OCTOBER 10, 2024

This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025. By harnessing the power of machine learning and big data, these startups are transforming the landscape of cardiovascular, renal, and metabolic care.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

American College of Cardiology

JUNE 6, 2024

The ACC submitted formal comments on June 5 to the Centers for Medicare and Medicaid Services (CMS) regarding the Fiscal Year (FY) 2025 Inpatient Prospective Payment System (IPPS) proposed rule.

CMS 44

CMS Reimbursement Medicaid Medicare 44

American College of Cardiology

APRIL 12, 2024

The Centers for Medicare and Medicaid Services (CMS) released the Fiscal Year (FY) 2025 Inpatient Prospective Payment System (IPPS) proposed rule, proposing a 2.6% increase in operating payment rates for applicable hospitals. This represents a 3% projected increase in the hospital market basket update with a projected 0.4%

CMS 48

CMS Hospital Medicaid Medicare 48

Becker's Hospital Review - Cardiology

OCTOBER 30, 2024

Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in vascular surgery.

Hospital 105

Hospital Outcomes 105

Becker's Hospital Review - Cardiology

OCTOBER 23, 2024

Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in cardiac surgery.

Hospital 111

Hospital Outcomes 111

HCPLive

OCTOBER 10, 2024

Based on the regulatory feedback provided by the FDA, Nanoscope announced plans to initiate Biologics License Application submission in Q1 2025.

122

122

HCPLive

NOVEMBER 18, 2024

In these updates and new sections, the 2025 GOLD report included highlighted climate change, cardiovascular risk, and pulmonary hypertension.

Pulmonary 64

Pulmonary Hypertension 64

HCPLive

SEPTEMBER 24, 2024

The FDA has set a PDUFA target action date of May 22, 2025, for roflumilast foam 0.3% for individuals aged ≥12 with scalp and body psoriasis.

111

111

Becker's Hospital Review - Cardiology

JULY 23, 2024

News' 2024-2025 ranking, evaluating nearly 800 hospitals for challenging heart and vascular Discover the top heart hospitals in every state according to U.S.

Hospital 124

Hospital 124

HCPLive

NOVEMBER 19, 2024

This segment of Han’s interview featured a discussion of the safety profile of dupilumab and ensifentrine, as well as other details in the GOLD 2025 Report.

52

52

Becker's Hospital Review - Cardiology

NOVEMBER 12, 2024

Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. Of those, 99 hospitals were recognized for delivering superior clinical outcomes in the care and treatment of stroke.

Hospital 59

Hospital Stroke Strokes Outcomes 59

HCPLive

JULY 25, 2024

The sNDA for furosemide seeks to expand the indication to include the treatment of edema due to fluid overload in patients with CKD, with a PDUFA date of March 6, 2025.

Kidney Disease 109

Kidney Disease 109

HCPLive

OCTOBER 22, 2024

Ustekinumab-aekn is set to enter the US market no later than February 21, 2025, as per a settlement and license agreement between Janssen, Teva, and Alvotech.

59

59

HCPLive

MAY 19, 2024

During AAPA 2024, a group of session presenters provide recommendations for the next year's agenda based on trends and development.

64

64

HCPLive

OCTOBER 14, 2024

The ustekinumab biosimilar will be available in early 2025, with indications to treat psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.

59

59

HCPLive

OCTOBER 21, 2024

Novo Nordisk will present more detailed data in 2025 and plans to file for an expanded label for Rybelsus for this population.

Diabetes 59

Diabetes 59

DAIC

NOVEMBER 15, 2024

HIMSS Global Health Conference & Exhibition will take place in Las Vegas, March 3-6, 2025. Register by December 15 to save up to $500 on your pass for the HIMSS Global Health Conference & Exhibition. For more information, please visit www.himssconference.com If you enjoy this content, please share it with a colleague

52

52

American College of Cardiology

OCTOBER 8, 2024

The ACC has named Renuka Jain, MD, FACC, as the incoming chair-elect of its Board of Governors, beginning April 2025 following ACC.25 25 in Chicago, IL. She will replace David E. Winchester, MD, MS, FACC, as BOG Chair for 2026 to 2027.

Article 70

Article 70

HCPLive

FEBRUARY 27, 2024

is voluntarily recalling eye ointment products with expiration dates from February 2024 to September 2025. Brassica Pharma Pvt.

105

105

HCPLive

OCTOBER 24, 2024

Aquestive Therapeutics plans to submit an NDA for Anaphylm in Q1 2025 based on topline results from the Oral Allergy Syndrome challenge study.

52

52

DAIC

JULY 29, 2024

Edwards anticipates FDA approval of the JenaValve Trilogy Heart Valve System in late 2025, which will represent the first approved therapy for patients suffering from AR. A CMS national coverage determination is expected in early 2025. Edwards expects minimal revenue contribution from these acquisitions in 2025.

Innovation 98

Innovation Aortic valve Aortic CMS 98

Becker's Hospital Review - Cardiology

JULY 16, 2024

for 2024-2025, according to U.S. Discover the top-ranked heart hospital in the U.S. See the full list of top 10 hospitals for heart programs

Hospital 69

Hospital 69

HCPLive

JUNE 25, 2024

FDA accepts a supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with PTSD, with a PDUFA date of February 8, 2025.

64

64

DAIC

JULY 18, 2024

In accordance with the AMA semi-annual early release schedule, the new codes will be effective January 1st, 2025 and published in the 2025 CPT Code book. CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement.

Reimbursement 105

Reimbursement Electrocardiogram Technology Medicaid 105

American Heart News - Stroke News

OCTOBER 1, 2024

DALLAS, 1 de octubre de 2024 - Los derrames cerebrales pueden producirse a cualquier edad, lo que obliga a los supervivientes a superar cambios físicos, emocionales y cognitivos. Ya está abierto el plazo de presentación de candidaturas para los.

Stroke 55

Stroke Strokes 55

Society of Thoracic Surgeons - Early Career

AUGUST 29, 2024

Application Deadline for 2025 Thoracic Surgery Foundation Scholarships Is September 15, 2024 In 2023, Dr. Chizoba Efobi was awarded the Thoracic Surgery Foundation (TSF) International Medical Volunteer Scholarship and used it to participate in a surgical outreach trip to Kampala, Uganda.

52

52

HCPLive

MAY 13, 2024

Sadda, MD, became the organization's president for the 2024-2025 year. At the end of ARVO 2024, Srinivas R. He spoke to HCPLive about his expectations for the next year in eye care.

64

64

Clinical Trial Results

NOVEMBER 18, 2024

Mikhail Kosiborod will become an AstraZeneca BioPharmaceuticals Research and Development Employee as Senior Vice President for Late Stage Cardiovascular, Renal and Metabolic Disease, effective January 6th 2025; this role entails development oversight for several compounds, including SZC, which was tested during the REALIZE-K Trial.

Download 40

Download Academic Heart Failure Research 40